Tamoxifen for Testosterone Recovery in Prostate Cancer

(REVIVE Trial)

This trial explores whether Tamoxifen can help men recover testosterone levels faster after prostate cancer treatment. Men who have undergone androgen deprivation therapy, a common prostate cancer treatment that reduces testosterone, often face delayed testosterone recovery, leading to various side effects. The trial compares two groups: one taking Tamoxifen and another under observation without additional treatment. Men who have completed androgen deprivation therapy for prostate cancer and meet certain criteria might be eligible. Eligibility includes having low testosterone levels after treatment and no ongoing use of certain medications or health conditions like blood clots or liver issues. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important advancements in prostate cancer recovery.

The trial requires that you stop taking certain medications, such as specific antidepressants (SSRIs like paroxetine), anticoagulants, cytotoxic agents, and aromatase inhibitors. If you are on any of these, you would need to discontinue them to participate.

Previous studies have shown that Tamoxifen is safe and well-tolerated by patients with prostate cancer. Research indicates that Tamoxifen can help prevent side effects like breast enlargement and breast pain in patients receiving hormone therapy to lower testosterone. This suggests it may be a comfortable option for those seeking to speed up testosterone recovery after this therapy.

Most treatments for prostate cancer focus on directly reducing testosterone levels, often through androgen deprivation therapy (ADT), which can cause various side effects and take time for testosterone levels to recover after stopping treatment. However, tamoxifen is unique because it may aid in the recovery of testosterone levels after ADT. Tamoxifen works differently by blocking estrogen receptors, potentially helping to restore testosterone more quickly and comfortably. Researchers are excited about tamoxifen because it offers a new approach that could improve the quality of life for patients by speeding up testosterone recovery without the need for additional hormone therapy.

This trial will compare Tamoxifen treatment with observation for testosterone recovery in prostate cancer patients. Studies have shown that Tamoxifen can alleviate symptoms related to hormone therapy in these patients. Specifically, one study found that taking 20 mg of Tamoxifen daily reduced the severity of these symptoms. Research indicates that many men do not fully regain testosterone levels after hormone therapy, and Tamoxifen may assist in this recovery. Another study suggested that recovering testosterone levels is linked to better overall survival in prostate cancer patients. While Tamoxifen is well-known for treating breast cancer, it offers a promising approach to help men with prostate cancer recover testosterone levels.¹⁶⁷⁸⁹